Potassium Chloride
NDC 71610-977, Potassium Chloride, tablet, extended release, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-977
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218979
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-977 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CHLORIDE750 mg/1
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-977-30 | 71610097730 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-30) |
| 71610-977-53 | 71610097753 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-53) |
| 71610-977-60 | 71610097760 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-60) |
| 71610-977-70 | 71610097770 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-70) |
| 71610-977-73 | 71610097773 | 135 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-73) |
| 71610-977-80 | 71610097780 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-80) |
| 71610-977-85 | 71610097785 | 200 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-85) |
| 71610-977-92 | 71610097792 | 270 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-92) |
| 71610-977-94 | 71610097794 | 360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-977-94) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/471f3a39-5fea-cd7a-e063-6294a90a0d93
Use it
Look up 71610-977 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-977 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-977. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.